• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[癫痫的新型治疗方法——脑起搏器和经颅磁刺激]

[Newer treatment of epilepsy--brain pacemakers and transcranial magnetic stimulation].

作者信息

Akamatsu Naoki

机构信息

Department of Neurology, University of Occupational and Environmental Health School of Medicine.

出版信息

Rinsho Shinkeigaku. 2005 Nov;45(11):928-30.

PMID:16447765
Abstract

The antiepileptic medication and surgical treatment had brought many patients with epilepsy to be seizure free, however, one third of the patients continue to experience seizures. There has recently been an explosion of research into brain stimulation for treating these intractable epilepsy patients. This is largely due to the success of deep brain stimulation of movement disorders. The intelligent cardiac pacemakers also stimulated the neurosurgeons to utilize the implantable devices. In this paper, brain stimulations with vagus nerve stimulator (VNS), depth electrodes, subdural electrodes, external responsive neuro-stimulator, implantable brain stimulator and transcranial magnetic stimulator are reviewed. The VNS had been approved in Europe and United States for clinical use. The efficacy of the VNS has already proven by the controlled trials. Stimulation of the thalamus, subthalamic nucleus and hippocampus showed some efficacy in a small number of patients, however, large scale traials remains to be undertaken. External responsive neurostimulator has shown efficacy and safety to justify further studies with implantable brain stimulators. The multi-center cooperative study is ongoing in the US to examine the usefulness of the implantable stimulator. Animal studies showed efficacy of the transcranial magnetic stimulation for the treatment and prevention of the seizures and status epilepticus.

摘要

抗癫痫药物和手术治疗已使许多癫痫患者不再发作,然而,仍有三分之一的患者继续遭受癫痫发作。最近,针对这些难治性癫痫患者的脑刺激研究激增。这主要归因于深部脑刺激治疗运动障碍的成功。智能心脏起搏器也促使神经外科医生利用可植入设备。本文综述了迷走神经刺激器(VNS)、深度电极、硬膜下电极、外部响应神经刺激器、可植入脑刺激器和经颅磁刺激器的脑刺激情况。VNS已在欧洲和美国获批用于临床。VNS的疗效已通过对照试验得到证实。刺激丘脑、丘脑底核和海马体在少数患者中显示出一定疗效,然而,仍有待进行大规模试验。外部响应神经刺激器已显示出疗效和安全性,可为进一步研究可植入脑刺激器提供依据。美国正在进行多中心合作研究,以检验可植入刺激器的效用。动物研究表明经颅磁刺激对癫痫发作和癫痫持续状态的治疗及预防有效。

相似文献

1
[Newer treatment of epilepsy--brain pacemakers and transcranial magnetic stimulation].[癫痫的新型治疗方法——脑起搏器和经颅磁刺激]
Rinsho Shinkeigaku. 2005 Nov;45(11):928-30.
2
[Deep brain stimulation for epilepsy].[用于癫痫的深部脑刺激]
Brain Nerve. 2011 Apr;63(4):365-9.
3
Modern management of epilepsy: Vagus nerve stimulation.癫痫的现代管理:迷走神经刺激术。
Baillieres Clin Neurol. 1996 Dec;5(4):841-8.
4
Devices in the treatment of epilepsy.用于癫痫治疗的设备。
Semin Neurol. 2002 Sep;22(3):259-68. doi: 10.1055/s-2002-36646.
5
[Less invasive treatment of intractable epilepsy--vagus nerve stimulation and stereotactic radiosurgery].[难治性癫痫的微创治疗——迷走神经刺激术和立体定向放射外科手术]
Brain Nerve. 2007 Apr;59(4):299-311.
6
[Long-term efficiency of vagus nerve stimulation (VNS) in non-surgical refractory epilepsies in adolescents and adults].[迷走神经刺激术(VNS)对青少年及成人非手术难治性癫痫的长期疗效]
Rev Neurol (Paris). 2007 Dec;163(12):1169-77. doi: 10.1016/S0035-3787(07)78401-1.
7
Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study.迷走神经刺激治疗难治性癫痫:一项比利时多中心研究。
Eur J Paediatr Neurol. 2007 Sep;11(5):261-9. doi: 10.1016/j.ejpn.2007.01.008. Epub 2007 Mar 28.
8
Brain stimulation for epilepsy.用于癫痫的脑刺激
Nat Clin Pract Neurol. 2005 Dec;1(2):64-5. doi: 10.1038/ncpneuro0051.
9
Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long-term follow-up study.丘脑前核电刺激治疗难治性癫痫:一项长期随访研究。
Epilepsia. 2007 Feb;48(2):342-7. doi: 10.1111/j.1528-1167.2006.00898.x.
10
Vagus nerve stimulation therapy for seizures.用于癫痫治疗的迷走神经刺激疗法。
J Neurosurg Anesthesiol. 2008 Jan;20(1):29-35. doi: 10.1097/ANA.0b013e31815b7df1.